Heart Disease Complicated by HIV Infection: Predictors, Diagnosis and Treatment Options
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".
Deadline for manuscript submissions: 20 June 2024 | Viewed by 135
Special Issue Editor
Special Issue Information
Dear Colleagues,
Over the last two decades, following the introduction of potent high-genetic barrier regimens in the aging population, HIV medicine has progressively focused on comorbidities and age-related health issues. People living with HIV (PLWH) are disproportionally affected by cardiovascular disease (both in terms of morbidity and mortality) which is not entirely explained by the traditional risk factors, such as age, gender, smoker status, diabetes, family history, hypertension, and weight.
Several studies have addressed the additional role of HIV-related immune activation and inflammation, but many questions remain open. HIV infection is considered an independent predictor of heart disease, meaning it should be managed accordingly, although real-life data report an insufficient level of medical attention and patient compliance.
Heart disease requires multilevel interventions, more aggressive investigations, higher clinician and patient awareness, along with treatment optimization. Antiretrovirals and the potential for drug-to-drug interactions may also complicate this scenario.
More studies are needed in this population to refine the risk prediction tools, identify subclinical diseases, provide recommendations, and standardize management.
The aim of this Special Issue is to focus on the peculiarity of cardiovascular disease in PLWH, addressing the clinical issue in terms of prediction tools, pathogenesis, and treatment options.
Dr. Diego Ripamonti
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cardiovascular disease
- HIV infection
- HAART
- biomarkers
- coronary artery diseases
- inflammation
- arterial stiffness
